HIV/AIDS research in Africa and the Middle East: participation and equity in North-South collaborations and relationships

Table 5 MeSH qualifiers of HIV/AIDS research papers, according to African involvement, 2010–2017

Qualifier	Global publications		Solely African publications		African + global collaborations
Qualifier	N	%	N	%	N	%
Epidemiology	53,262	77.41	1220	42.90	5293	44.24
Immunology	49,149	71.43	378	13.29	1805	15.09
Genetics	38,248	55.59	264	9.28	1584	13.24
Metabolism	33,536	48.74	174	6.12	668	5.58
Drug therapy	30,764	44.71	978	34.39	4783	39.98
Therapeutic use	29,749	43.23	681	23.95	3798	31.75
Virology	28,082	40.81	462	16.24	2478	20.71
Complications	25,058	36.42	728	25.60	2338	19.54
Psychology	22,690	32.98	529	18.60	1930	16.13
Prevention & control	18,924	27.50	639	22.47	3212	26.85
Statistics & numerical data	18,496	26.88	498	17.51	2255	18.85
Diagnosis	17,732	25.77	605	21.27	2362	19.74
Drug effects	17,645	25.64	224	7.88	1106	9.24
Blood	15,949	23.18	301	10.58	1262	10.55
Chemistry	15,720	22.85	119	4.18	346	2.89
Administration & dosage	15,703	22.82	218	7.67	1461	12.21
Methods	15,141	22.00	437	15.37	2223	18.58
Pharmacology	14,377	20.89	135	4.75	739	6.18
Pathology	11,124	16.17	186	6.54	654	5.47
Adverse effects	11,122	16.16	213	7.49	798	6.67
Physiology	10,677	15.52	106	3.73	511	4.27
Isolation & purification	8327	12.10	261	9.18	1310	10.95
Transmission	8090	11.76	296	10.41	1546	12.92
Etiology	6038	8.78	249	8.76	579	4.84
Economics	5835	8.48	84	2.95	577	4.82
Therapy	5416	7.87	196	6.89	525	4.39
Microbiology	5377	7.81	181	6.36	718	6.00
Ethnology	5007	7.28	66	2.32	237	1.98
Mortality	4689	6.81	148	5.20	712	5.95
Pharmacokinetics	4033	5.86	21	0.74	220	1.84
Physiopathology	3912	5.69	89	3.13	255	2.13

ISSN: 1744-8603